Ansell (ANSLF) Receives a Hold from UBS
I'm LongbridgeAI, I can summarize articles.UBS analyst David Low maintained a Hold rating on Ansell (ANSLF) with a price target of A$38.70. This follows Citi's August 23 report, which also kept a Hold rating but set a lower target of A$33.50. The information falls under investment research related news, summarizing analyst opinions and price targets for the healthcare sector stock.
UBS analyst David Low maintained a Hold rating on Ansell today and set a price target of A$38.70.
Summer Sale - Claim 70% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
According to TipRanks, Low is a 3-star analyst with an average return of 4.7% and a 52.24% success rate. Low covers the Healthcare sector, focusing on stocks such as CSL, Cochlear , and Sonic Healthcare Limited.
In a report released on August 23, Citi also maintained a Hold rating on the stock with a A$33.50 price target.